Tetsuya Tanimoto

18PUBLICATIONS
35CO-AUTHORS
PharmacogenomicsRegenerative medicine (incl. stem cells)Risk policyPredictive and prognostic markersNot-for-profit accounting and accountability
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 26, 2025
Added Therapeutic Benefits of Top-Selling Drugs in Japan: A Cross-Sectional Study Using Health Technology Assessment.

|Jan 14, 2025
Japan's Conditional/Time-Limited Early Approval System in Regenerative Medicine: A Case Study of Rise and Falls of Autologous Skeletal Myoblast Sheets.

Hayase Hakariya, Akihiko Ozaki, Yudai Kaneda

|Jul 22, 2024
Risk Index of Regional Infection Expansion of COVID-19: Moving Direction Entropy Study Using Mobility Data and Its Application to Tokyo.

Yukio Ohsawa, Yi Sun, Kaira Sekiguchi

|Jul 11, 2024
Continued cancer drug approvals in Japan and Europe after market withdrawal in the United States: A comparative study of accelerated approvals.

Hayase Hakariya, Frank Moriarty, Akihiko Ozaki

|Apr 15, 2024
Characteristics and Distribution of Scholarship Donations From Pharmaceutical Companies to Japanese Healthcare Institutions in 2017: A Cross-sectional Analysis.

Anju Murayama, Sae Kamamoto, Hiroaki Saito

|Sep 08, 2019
Physician Decision-Making Patterns and Family Presence: Cross-Sectional Online Survey Study in Japan.

Kenji Tsuda, Asaka Higuchi, Emi Yokoyama

Pageof 3

Frequent Collaborators

6 joint publications

Hayase Hakariya

5 joint publications

Akihiko Ozaki

4 joint publications

Motoharu Shibusawa

3 joint publications

Frank Moriarty